HEG Q3 FY26 Results: PAT Surges, INR 400 Cr OCDs in TACC

Revenue Growth 20pctPat Growth 25pctEmphasis Of MatterRelated Party TransactionsResults View source PDF Explain this filing

HEG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.6%Reaction day

₹557.50

prior close

₹594.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.1%-5.7% vs market

Electrodes & Refractories peers, median of 10sector-1.3%-4.3% vs sector

On the reaction day the stock moved 5.7 pts less than Nifty Smallcap 250 and 4.3 pts less than its Electrodes & Refractories peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.6

10m

-4.7

15m

-5.5

30m

-9.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.6+0.1-5.7-1.3-4.3

Next day

-4.8-0.6-4.1-1.8-3.0

-5.8-2.2-3.6-4.5-1.3

-4.7-2.3-2.5-5.6+0.9

-6.0-1.5-4.4-5.2-0.8

-0.9-1.0+0.1-5.2+4.3

+0.3-2.4+2.6-8.1+8.4

15d

-2.8-5.4+2.6-12.8+10.0

-5.8-6.3+0.5-12.1+6.4

+1.3-4.0+5.4-9.7+11.1

+5.9+5.5+0.4-4.9+10.8

UpDownMarket · Nifty Smallcap 250Sector · Electrodes & Refractories peers, median of 10Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

HEG posted strong Q3 FY26 results. Standalone 9M revenue grew 22 percent to INR 1,965 Cr, PAT doubled to INR 344 Cr. Consolidated 9M PAT nearly quadrupled to INR 455 Cr. Board approved INR 400 Cr OCD subscription in TACC subsidiary, corporate guarantee for SBI credit facilities to TACC, and winding up of medical transcription unit. Auditor flagged emphasis of matter on BEL associate subsidiaries NHPL and CYHPL over stalled hydro projects.

Likely market impact

Strong earnings, large capital infusion in subsidiary, and minor business exit. Emphasis of matter on associate subsidiaries may concern investors.